[EN] NOVEL THERAPEUTIC USE OF INDOLINONE DERIVATIVES<br/>[FR] NOUVELLE UTILISATION THERAPEUTIQUE DE DERIVES D'INDOLINONE
申请人:LEO PHARMA AS
公开号:WO2005058309A1
公开(公告)日:2005-06-30
Certain oxindole compounds have been found to be effective in experimentally induced autoimmune encephalitis and are therefore suggested for the preparation of a medicament for the prevention, treatment or amelioration of multiple sclerosis, or to delay the onset of or reduce the relapse rate in multiple sclerosis.
CeCl<sub>3</sub>·7H<sub>2</sub>O catalyzed C(sp<sup>2</sup>)−CN bond construction on water: Synthesis of (<i>Z</i>)-2-(2-Oxoindolin-3-ylidene)-2-arylacetonitriles
作者:Yan Du、Zheng Li
DOI:10.1080/00397911.2018.1540050
日期:2019.1.2
Abstract An environmentallyfriendly method for the construction of C(sp2)-CN bond on water has been described, and (Z)-2-(2-oxoindolin-3-ylidene)-2-arylacetonitriles were synthesized by using CeCl3· 7H2O as a catalyst. The reaction offers access to alkenyl nitriles in good-to-excellent yield. The investigations will be beneficial to reduce the use of toxic organic solvents and explore the efficient
Certain oxindole compounds have been found to be effective in experimentally induced autoimmune encephalitis and are therefore suggested for the preparation of a medicament for the prevention, treatment or amelioration of multiple sclerosis, or to delay the onset of or reduce the relapse rate in multiple sclerosis.
Functionalized 3-benzylidene-indolin-2-ones: Inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity
作者:Wei Zhang、Mei-Lin Go
DOI:10.1016/j.bmc.2008.12.052
日期:2009.3
Functionalized benzylidene-indolin-2-ones are widely associated with antiproliferative activity. The scaffold is not normally associated with chemoprevention in spite of the presence of a nitrogen-linked Michael acceptor moiety that may predispose members to induction of NQO1, a widely used biomarker of chemopreventive potential. To investigate this possibility, we have synthesized and evaluated a series of functionalized 3-benzylidene-indolin-2-ones for induction of NQO1 in murine Hepa1c1c7 cells as well as antiproliferative activity against two human cancer cell lines (MCF-7, HCT116). The benzylideneindolinones were found to be good inducers of NQO1 activity, with 85% of test compounds able to increase basal NQO1 activity by more than twofold at concentrations of <= 10 mu M. By contrast, fewer compounds (11%) tested at the same concentration were able to reduce cell viability by more than 50%. Structure activity relationships showed that the nitrogen linked Michael acceptor moiety was an essential requirement for both activities. This common feature notwithstanding, substitution of the 3-benzylidene-indolin-2-one core structure affected NQO1 induction and antiproliferative activities in dissimilar ways, underscoring different structural requirements for these two activities. Nonetheless, promising compounds ( 10, 42, 45-48) were identified that combine selective induction of NQO1 with potent antiproliferative activity. A potential advantage of such agents would be the ability to provide added protection to normal cells by the up-regulation of NQO1 and other phase II enzymes while simultaneously targeting neoplastic cells. (C) 2008 Elsevier Ltd. All rights reserved.
Indolin-2-ones with High in Vivo Efficacy in a Model for Multiple Sclerosis
作者:Laëtitia Bouérat、Jef Fensholdt、Xifu Liang、Sophie Havez、Simon F. Nielsen、Jens R. Hansen、Simon Bolvig、Christina Andersson
DOI:10.1021/jm0504151
日期:2005.8.1
The known KDR inhibitor SU5416 and several analogues of the indolin-2-one family were surprisingly found to be highly efficacious in the EAE model, an established model for multiple sclerosis. The high in vivo effect could be correlated to in vitro inhibition of the pro-inflammatory cytokine IL-2. Activity following po administration was obtained with several analogues and via the use of prodrugs.